RAYMOND JAMES & ASSOCIATES - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 276 filers reported holding GW PHARMACEUTICALS PLC in Q3 2018. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$1,208,000
+21.4%
5,570
-35.4%
0.00%0.0%
Q4 2020$995,000
-54.8%
8,625
-61.8%
0.00%
-66.7%
Q3 2020$2,199,000
+18.1%
22,591
+48.9%
0.00%
+50.0%
Q2 2020$1,862,000
+39.1%
15,176
-0.8%
0.00%0.0%
Q1 2020$1,339,000
-15.1%
15,296
+1.4%
0.00%0.0%
Q4 2019$1,578,000
-9.1%
15,091
-0.0%
0.00%0.0%
Q3 2019$1,736,000
-41.8%
15,092
-12.8%
0.00%
-50.0%
Q2 2019$2,983,000
-3.0%
17,301
-5.2%
0.00%
-20.0%
Q1 2019$3,076,000
+42.1%
18,249
-17.9%
0.01%
+25.0%
Q4 2018$2,164,000
-51.2%
22,217
-13.5%
0.00%
-42.9%
Q3 2018$4,438,000
+52.2%
25,691
+22.9%
0.01%
+40.0%
Q2 2018$2,916,000
+120.1%
20,900
+77.8%
0.01%
+150.0%
Q1 2018$1,325,000
+18.6%
11,757
+38.9%
0.00%0.0%
Q4 2017$1,117,000
+42.1%
8,464
+9.3%
0.00%0.0%
Q3 2017$786,000
+12.3%
7,746
+10.9%
0.00%0.0%
Q2 2017$700,000
+3.2%
6,983
+24.5%
0.00%0.0%
Q1 2017$678,000
+55.5%
5,609
+43.9%
0.00%
+100.0%
Q4 2016$436,000
+7.7%
3,898
+27.7%
0.00%0.0%
Q3 2016$405,0003,0520.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders